Rapid measurement of insulin using the Abbott IMx: Application to the management of insulinoma

S. V. Albright, J. A. McCart, S. K. Libutti, D. L. Bartlett, H. R. Alexander, M. L. Sampson, M. E. Ruddel, A. T. Remaley

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: Patients with multiple endocrine neoplasia (type 1) often present with multiple pancreatic endocrine tumours, such as insulinomas. A major difficulty in the surgical treatment of such patients is identifying which tumours are functionally active and therefore need to be resected for a cure. The objective of this study was to develop a rapid insulin assay that could be used intraoperatively for identifying insulinomas from pancreatic aspirates. Methods: By reducing the incubation time and by increasing the sample volume, a rapid insulin assay was developed on the IMx analyser. This was used to measure insulin from tissue aspirates collected from suspected insulinomas under ultrasound guidance. Results: The rapid insulin assay (y) could be performed in 14 min and showed a good correlation with the standard IMx (x) insulin assay (y=0.808x+0.04; r2=0.986). Using the rapid insulin assay on pancreatic tissue aspirates, insulinomas could be readily distinguished from normal pancreatic tissue or from non-functional adenomas based on a marked increase in insulin content. Conclusion: In summary, a new rapid assay for insulin is described that compares favourably to the standard IMx insulin assay and can potentially be used intraoperatively on pancreatic aspirates for identifying functionally active insulinomas.

Original languageEnglish (US)
Pages (from-to)513-515
Number of pages3
JournalAnnals of Clinical Biochemistry
Volume39
Issue number5
DOIs
StatePublished - Sep 2002
Externally publishedYes

Fingerprint

Insulinoma
Insulin
Assays
Tissue
Tumors
Multiple Endocrine Neoplasia Type 1
Adenoma
Neoplasms
Ultrasonics

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Albright, S. V., McCart, J. A., Libutti, S. K., Bartlett, D. L., Alexander, H. R., Sampson, M. L., ... Remaley, A. T. (2002). Rapid measurement of insulin using the Abbott IMx: Application to the management of insulinoma. Annals of Clinical Biochemistry, 39(5), 513-515. https://doi.org/10.1258/000456302320314548

Rapid measurement of insulin using the Abbott IMx : Application to the management of insulinoma. / Albright, S. V.; McCart, J. A.; Libutti, S. K.; Bartlett, D. L.; Alexander, H. R.; Sampson, M. L.; Ruddel, M. E.; Remaley, A. T.

In: Annals of Clinical Biochemistry, Vol. 39, No. 5, 09.2002, p. 513-515.

Research output: Contribution to journalArticle

Albright, SV, McCart, JA, Libutti, SK, Bartlett, DL, Alexander, HR, Sampson, ML, Ruddel, ME & Remaley, AT 2002, 'Rapid measurement of insulin using the Abbott IMx: Application to the management of insulinoma', Annals of Clinical Biochemistry, vol. 39, no. 5, pp. 513-515. https://doi.org/10.1258/000456302320314548
Albright, S. V. ; McCart, J. A. ; Libutti, S. K. ; Bartlett, D. L. ; Alexander, H. R. ; Sampson, M. L. ; Ruddel, M. E. ; Remaley, A. T. / Rapid measurement of insulin using the Abbott IMx : Application to the management of insulinoma. In: Annals of Clinical Biochemistry. 2002 ; Vol. 39, No. 5. pp. 513-515.
@article{2ec12d969e5f4ccfa4ed1bd77a176b2c,
title = "Rapid measurement of insulin using the Abbott IMx: Application to the management of insulinoma",
abstract = "Background: Patients with multiple endocrine neoplasia (type 1) often present with multiple pancreatic endocrine tumours, such as insulinomas. A major difficulty in the surgical treatment of such patients is identifying which tumours are functionally active and therefore need to be resected for a cure. The objective of this study was to develop a rapid insulin assay that could be used intraoperatively for identifying insulinomas from pancreatic aspirates. Methods: By reducing the incubation time and by increasing the sample volume, a rapid insulin assay was developed on the IMx analyser. This was used to measure insulin from tissue aspirates collected from suspected insulinomas under ultrasound guidance. Results: The rapid insulin assay (y) could be performed in 14 min and showed a good correlation with the standard IMx (x) insulin assay (y=0.808x+0.04; r2=0.986). Using the rapid insulin assay on pancreatic tissue aspirates, insulinomas could be readily distinguished from normal pancreatic tissue or from non-functional adenomas based on a marked increase in insulin content. Conclusion: In summary, a new rapid assay for insulin is described that compares favourably to the standard IMx insulin assay and can potentially be used intraoperatively on pancreatic aspirates for identifying functionally active insulinomas.",
author = "Albright, {S. V.} and McCart, {J. A.} and Libutti, {S. K.} and Bartlett, {D. L.} and Alexander, {H. R.} and Sampson, {M. L.} and Ruddel, {M. E.} and Remaley, {A. T.}",
year = "2002",
month = "9",
doi = "10.1258/000456302320314548",
language = "English (US)",
volume = "39",
pages = "513--515",
journal = "Annals of Clinical Biochemistry",
issn = "0004-5632",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - Rapid measurement of insulin using the Abbott IMx

T2 - Application to the management of insulinoma

AU - Albright, S. V.

AU - McCart, J. A.

AU - Libutti, S. K.

AU - Bartlett, D. L.

AU - Alexander, H. R.

AU - Sampson, M. L.

AU - Ruddel, M. E.

AU - Remaley, A. T.

PY - 2002/9

Y1 - 2002/9

N2 - Background: Patients with multiple endocrine neoplasia (type 1) often present with multiple pancreatic endocrine tumours, such as insulinomas. A major difficulty in the surgical treatment of such patients is identifying which tumours are functionally active and therefore need to be resected for a cure. The objective of this study was to develop a rapid insulin assay that could be used intraoperatively for identifying insulinomas from pancreatic aspirates. Methods: By reducing the incubation time and by increasing the sample volume, a rapid insulin assay was developed on the IMx analyser. This was used to measure insulin from tissue aspirates collected from suspected insulinomas under ultrasound guidance. Results: The rapid insulin assay (y) could be performed in 14 min and showed a good correlation with the standard IMx (x) insulin assay (y=0.808x+0.04; r2=0.986). Using the rapid insulin assay on pancreatic tissue aspirates, insulinomas could be readily distinguished from normal pancreatic tissue or from non-functional adenomas based on a marked increase in insulin content. Conclusion: In summary, a new rapid assay for insulin is described that compares favourably to the standard IMx insulin assay and can potentially be used intraoperatively on pancreatic aspirates for identifying functionally active insulinomas.

AB - Background: Patients with multiple endocrine neoplasia (type 1) often present with multiple pancreatic endocrine tumours, such as insulinomas. A major difficulty in the surgical treatment of such patients is identifying which tumours are functionally active and therefore need to be resected for a cure. The objective of this study was to develop a rapid insulin assay that could be used intraoperatively for identifying insulinomas from pancreatic aspirates. Methods: By reducing the incubation time and by increasing the sample volume, a rapid insulin assay was developed on the IMx analyser. This was used to measure insulin from tissue aspirates collected from suspected insulinomas under ultrasound guidance. Results: The rapid insulin assay (y) could be performed in 14 min and showed a good correlation with the standard IMx (x) insulin assay (y=0.808x+0.04; r2=0.986). Using the rapid insulin assay on pancreatic tissue aspirates, insulinomas could be readily distinguished from normal pancreatic tissue or from non-functional adenomas based on a marked increase in insulin content. Conclusion: In summary, a new rapid assay for insulin is described that compares favourably to the standard IMx insulin assay and can potentially be used intraoperatively on pancreatic aspirates for identifying functionally active insulinomas.

UR - http://www.scopus.com/inward/record.url?scp=0036729744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036729744&partnerID=8YFLogxK

U2 - 10.1258/000456302320314548

DO - 10.1258/000456302320314548

M3 - Article

C2 - 12227859

AN - SCOPUS:0036729744

VL - 39

SP - 513

EP - 515

JO - Annals of Clinical Biochemistry

JF - Annals of Clinical Biochemistry

SN - 0004-5632

IS - 5

ER -